AFFINITY DUCHENNE Trademark

Trademark Overview

On Monday, November 15, 2021, a trademark application was filed for AFFINITY DUCHENNE with the United States Patent and Trademark Office. The USPTO has given the AFFINITY DUCHENNE trademark a serial number of 97125435. The federal status of this trademark filing is REGISTERED as of Tuesday, October 17, 2023. This trademark is owned by REGENXBIO Inc.. The AFFINITY DUCHENNE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the field of clinical trials; medical and scientific research, namely, conducting clinical trials for others
affinity duchenne

General Information

Serial Number97125435
Word MarkAFFINITY DUCHENNE
Filing DateMonday, November 15, 2021
Status700 - REGISTERED
Status DateTuesday, October 17, 2023
Registration Number7197150
Registration DateTuesday, October 17, 2023
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 4, 2022

Trademark Statements

Description of MarkThe mark consists of a sequence of dots with the words "AFFINITY DUCHENNE" written to the right side. The A in the word "AFFINITY" is written in a stylized font.
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"DUCHENNE"
Goods and ServicesProviding medical and scientific research information in the field of clinical trials; medical and scientific research, namely, conducting clinical trials for others

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 19, 2021
Primary Code042
First Use Anywhere DateThursday, January 6, 2022
First Use In Commerce DateThursday, January 6, 2022

Trademark Owner History

Party NameREGENXBIO Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameREGENXBIO Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameREGENXBIO Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events

Event DateEvent Description
Thursday, November 18, 2021NEW APPLICATION ENTERED
Friday, November 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 20, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, August 25, 2022ASSIGNED TO EXAMINER
Monday, August 29, 2022EXAMINERS AMENDMENT -WRITTEN
Monday, August 29, 2022EXAMINERS AMENDMENT E-MAILED
Monday, August 29, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, August 29, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, August 30, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 4, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 4, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 29, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 24, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, May 24, 2023SOU EXTENSION 1 FILED
Wednesday, May 24, 2023SOU EXTENSION 1 GRANTED
Thursday, August 10, 2023TEAS STATEMENT OF USE RECEIVED
Friday, May 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, June 17, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, June 17, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, June 17, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 10, 2023USE AMENDMENT FILED
Sunday, August 20, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, August 20, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, September 12, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, September 13, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 17, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 17, 2023REGISTERED-PRINCIPAL REGISTER
Thursday, December 12, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 12, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 12, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

duchenne affinity trials clinical research medical scientific conducting others namely field information